CDNA
CareDx, Inc.
September 24, 2026 · market open
- Rarity
- 2.66
- Peak move
- +15.95%
- Float cap
- $2.5B
CareDx is a precision medicine company focused on transplant patients and organ health. It provides non-invasive molecular testing for heart, kidney, and lung transplants, laboratory products, digital health technologies, and patient solutions to clinicians and transplant centers. It also offers specialized pharmacy services that help transplant patients access and manage medications.
Where do you see this going?
no votes yetVoting closed at 4:00 PM ET.
What we found
1 event · 0 from SEC or newswire · 0 timed with the moveanalyst_ratingBTIG raised its price target on CareDx to $74 from $60 and kept a Buy rating after hosting investor talks with management, citing confidence following the positive transplant LCD resolution, core business growth, and the Naveris acquisition.